{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:31:08Z","timestamp":1792452668082,"version":"4.5.0"},"reference-count":54,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T00:00:00Z","timestamp":1535068800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Intestinal microbiota plays an important role in bile acid homeostasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To study the structure of the intestinal microbiota and its function in bile acid homeostasis in alcoholic patients based on the severity of alcoholic liver disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this prospective study, we included four groups of active alcoholic patients (N\u00a0=\u00a0108): two noncirrhotic, with (noCir_\n                      <jats:styled-content style=\"fixed-case\">AH<\/jats:styled-content>\n                      , n\u00a0=\u00a013) or without alcoholic hepatitis (noCir_no\n                      <jats:styled-content style=\"fixed-case\">AH<\/jats:styled-content>\n                      , n\u00a0=\u00a061), and two cirrhotic, with (Cir_\n                      <jats:styled-content style=\"fixed-case\">sAH<\/jats:styled-content>\n                      , n\u00a0=\u00a017) or without severe alcoholic hepatitis (Cir_no\n                      <jats:styled-content style=\"fixed-case\">AH<\/jats:styled-content>\n                      , n\u00a0=\u00a017). Plasma and faecal bile acid profiles and intestinal microbiota composition were assessed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Plasma levels of total bile acids (84.6 vs 6.8\u00a0\u03bcmol\/L,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&lt;\u00a00.001) and total ursodeoxycholic acid (1.3 vs 0.3\u00a0\u03bcmol\/L,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.03) were higher in cirrhosis with severe alcoholic hepatitis (Cir_\n                      <jats:styled-content style=\"fixed-case\">sAH<\/jats:styled-content>\n                      ) than Cir_no\n                      <jats:styled-content style=\"fixed-case\">AH<\/jats:styled-content>\n                      , whereas total faecal (2.4 vs 11.3,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.01) and secondary bile acids (0.7 vs 10.7,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&lt;\u00a00.01) levels were lower. Cir_\n                      <jats:styled-content style=\"fixed-case\">sAH<\/jats:styled-content>\n                      patients had a different microbiota than Cir_no\n                      <jats:styled-content style=\"fixed-case\">AH<\/jats:styled-content>\n                      patients: at the phyla level, the abundance of Actinobacteria (9 vs 1%,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.01) was higher and that of Bacteroidetes was lower (25 vs 40%,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.04). Moreover, the microbiota of Cir_\n                      <jats:styled-content style=\"fixed-case\">sAH<\/jats:styled-content>\n                      patients showed changes in the abundance of genes involved in 15 metabolic pathways, including upregulation of glutathione metabolism, and downregulation of biotin metabolism.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Patients with Cir_\n                      <jats:styled-content style=\"fixed-case\">sAH<\/jats:styled-content>\n                      show specific changes of the bile acid pool with a shift towards more hydrophobic and toxic species that may be responsible for the specific microbiota changes. Conversely, the microbiota may also alter the bile acid pool by transforming primary to secondary bile acids, leading to a vicious cycle.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/apt.14949","type":"journal-article","created":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T04:26:38Z","timestamp":1535084798000},"page":"961-974","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":109,"title":["Bile acid homeostasis and intestinal dysbiosis in alcoholic hepatitis"],"prefix":"10.1111","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0416-1584","authenticated-orcid":false,"given":"Dragos","family":"Ciocan","sequence":"first","affiliation":[{"name":"Inflammation Chimiokines et Immunopathologie DHU Hepatinov Facult\u00e9 de M\u00e9decine\u2010Universit\u00e9 Paris\u2010Sud\/Universit\u00e9 Paris\u2010Saclay INSERM UMR\u2010S 996 Clamart France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7161-9631","authenticated-orcid":false,"given":"Cosmin Sebastian","family":"Voican","sequence":"additional","affiliation":[{"name":"Inflammation Chimiokines et Immunopathologie DHU Hepatinov Facult\u00e9 de M\u00e9decine\u2010Universit\u00e9 Paris\u2010Sud\/Universit\u00e9 Paris\u2010Saclay INSERM UMR\u2010S 996 Clamart France"},{"name":"AP\u2010HP, Hepatogastroenterology and Nutrition H\u00f4pital Antoine\u2010B\u00e9cl\u00e8re Clamart France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Wrzosek","sequence":"additional","affiliation":[{"name":"Inflammation Chimiokines et Immunopathologie DHU Hepatinov Facult\u00e9 de M\u00e9decine\u2010Universit\u00e9 Paris\u2010Sud\/Universit\u00e9 Paris\u2010Saclay INSERM UMR\u2010S 996 Clamart France"},{"name":"AP\u2010HP, Hepatogastroenterology and Nutrition H\u00f4pital Antoine\u2010B\u00e9cl\u00e8re Clamart France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Hugot","sequence":"additional","affiliation":[{"name":"Inflammation Chimiokines et Immunopathologie DHU Hepatinov Facult\u00e9 de M\u00e9decine\u2010Universit\u00e9 Paris\u2010Sud\/Universit\u00e9 Paris\u2010Saclay INSERM UMR\u2010S 996 Clamart France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Rainteau","sequence":"additional","affiliation":[{"name":"UPMC Universit\u00e9 Paris 6 Sorbonne Universit\u00e9s Paris France"},{"name":"Inflammation\u2010Immunopathology\u2010Biotherapy Department (DHU i2B) INSERM\u2010ERL 1157 Paris France"},{"name":"UMR 7203 Laboratoire des Biomol\u00e9cules UPMC\/CNRS\/ENS Paris France"},{"name":"D\u00e9partement PM2 Plateforme de M\u00e9tabolomique APHP H\u00f4pital Saint Antoine Peptidomique et dosage de M\u00e9dicaments Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydie","family":"Humbert","sequence":"additional","affiliation":[{"name":"UPMC Universit\u00e9 Paris 6 Sorbonne Universit\u00e9s Paris France"},{"name":"Inflammation\u2010Immunopathology\u2010Biotherapy Department (DHU i2B) INSERM\u2010ERL 1157 Paris France"},{"name":"UMR 7203 Laboratoire des Biomol\u00e9cules UPMC\/CNRS\/ENS Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1813-5128","authenticated-orcid":false,"given":"Anne\u2010Marie","family":"Cassard","sequence":"additional","affiliation":[{"name":"Inflammation Chimiokines et Immunopathologie DHU Hepatinov Facult\u00e9 de M\u00e9decine\u2010Universit\u00e9 Paris\u2010Sud\/Universit\u00e9 Paris\u2010Saclay INSERM UMR\u2010S 996 Clamart France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9985-8725","authenticated-orcid":false,"given":"Gabriel","family":"Perlemuter","sequence":"additional","affiliation":[{"name":"Inflammation Chimiokines et Immunopathologie DHU Hepatinov Facult\u00e9 de M\u00e9decine\u2010Universit\u00e9 Paris\u2010Sud\/Universit\u00e9 Paris\u2010Saclay INSERM UMR\u2010S 996 Clamart France"},{"name":"AP\u2010HP, Hepatogastroenterology and Nutrition H\u00f4pital Antoine\u2010B\u00e9cl\u00e8re Clamart France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,8,24]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(87)90861-4"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.04.004"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24018"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310585"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2017.0067"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-23146-3"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2016.10.029"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.femsre.2004.09.003"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0509592103"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.04.026"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)80401-5"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00315.2013"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/acer.13498"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.03.031"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01536804"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2014.03.014"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2013.11.057"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e3282f4710a"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1994.tb00915.x"},{"issue":"8222","key":"e_1_2_7_21_1","first-page":"707","article-title":"Alcoholic liver disease: morphological manifestations. Review by an international group","volume":"1","year":"1981","journal-title":"Lancet"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.042"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2012.05.015"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.11.008"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2676"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-6-r60"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpbi.11"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-313432"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00380.2011"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174544"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28572"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/acer.12900"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24423"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/biof.8"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00465.2010"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ALC.0000108654.77178.03"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.66.6.2502-2512.2000"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-9877(86)90137-4"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840220113"},{"key":"e_1_2_7_40_1","article-title":"The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids","author":"Puri P","year":"2017","journal-title":"Hepatology"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2007.10.039"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.09.020"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-016-9769-7"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22627"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep13462"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.28510"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50118"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1079\/BJN20041386"},{"issue":"2","key":"e_1_2_7_49_1","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1128\/aem.62.2.656-661.1996","article-title":"Tauroconjugation of cholic acid stimulates 7 alpha\u2010dehydroxylation by fecal bacteria","volume":"62","author":"Eldere J","year":"1996","journal-title":"Appl Environ Microbiol"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00043.2007"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/25.12.1418"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1128\/JB.188.5.1979-1986.2006"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.07.046"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2000.19621"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00268.2014"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fapt.14949","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/apt.14949","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T17:30:36Z","timestamp":1694280636000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apt.14949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,24]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["10.1111\/apt.14949"],"URL":"https:\/\/doi.org\/10.1111\/apt.14949","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,24]]},"assertion":[{"value":"2018-03-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}